Wall Street RegretsThe regret calculator.

What if you'd held BCRX?

A $1,000 investment in BioCryst Pharmaceuticals, Inc. (BCRX) at the month-end close of 1994-03 would be worth $1,831 at the close of 2026-08 — +83.1% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $17,291.

$1,000 since 1994$1,831Total return+83.1%Multiple1.8×CAGR+1.9%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$1,831Gain+$831 (+83.1%)Multiple1.8×CAGR+1.9%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2000$3412001$1,5202002$2,5432003$10,4902004$1,4702005$1,7422006$6012007$8712008$1,6292009$7,3502010$1,5592011$1,9482012$4,0772013$7,0922014$1,3252015$8282016$9762017$1,5912018$2,0512019$1,2482020$2,9192021$1,3522022$7272023$8772024$1,6812025$1,3392026$1,291

    Every year, $1,000 from 1994

    YearValue of $1,000Year return
    1994$1,000
    1995$2,000+100.0%
    1996$3,541+77.0%
    1997$1,514-57.3%
    1998$1,5140.0%
    1999$6,378+321.4%
    2000$1,432-77.5%
    2001$856-40.2%
    2002$208-75.8%
    2003$1,481+613.5%
    2004$1,250-15.6%
    2005$3,622+189.8%
    2006$2,499-31.0%
    2007$1,336-46.5%
    2008$296-77.8%
    2009$1,397+371.5%
    2010$1,118-20.0%
    2011$534-52.2%
    2012$307-42.5%
    2013$1,643+435.2%
    2014$2,629+60.0%
    2015$2,231-15.1%
    2016$1,369-38.7%
    2017$1,062-22.4%
    2018$1,745+64.4%
    2019$746-57.2%
    2020$1,611+115.9%
    2021$2,995+85.9%
    2022$2,482-17.1%
    2023$1,295-47.8%
    2024$1,626+25.5%
    2025$1,686+3.7%
    2026$2,177+29.1%

    Best and worst month-end to buy

    The best single month-end close to have bought BCRX was 2002-06 ($0.87): $1,000 then is $11,575 today. The worst was 2000-08 ($31.94): $1,000 then is $315.

    FAQ

    What would $1,000 in BCRX be worth today?

    A $1,000 investment in BioCryst Pharmaceuticals, Inc. (BCRX) at the start of 1994 would be worth about $1,831 today, a total return of +83.1%. Dividends are reinvested in these figures.

    What were the best and worst years for BCRX?

    BioCryst Pharmaceuticals, Inc. (BCRX)'s strongest calendar year since 1994 was 2003, a +613.5% return — $1,000 held through that year became about $7,135 by year-end. Its weakest year was 2008, at -77.8%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in BCRX have grown?

    Investing $100 at the end of every month since 1994-03 would have grown to about $77,303 on $39,000 invested.

    Did BCRX beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $17,291. BCRX trailed the S&P 500 by +89.4% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    BioCryst Pharmaceuticals, Inc. (BCRX) historical total-return data from 1994-03 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.